Skip to content
Research Article Open access CC BY 3.0

Soluble Cytokine Receptor Subunits Modulate Catecholaminergic Cell Activity

Ankur Patel, Jagadeesh Batana, Ishdeep Narang, Steven S. Zalcman

International Neuropsychiatric Disease Journal · pp. 121–126 · Published 27 Jan 2014

10.9734/INDJ/2014/7231

Abstract

Soluble cytokine receptors (SCR) modulate cytokine signaling and are increased in states of abnormal immune activation. SCR’s are also increased in psychiatric and neurological disorders associated with altered brain catecholaminergic activity; although, there is no evidence that any soluble cytokine receptor alone modulates such activity. One such soluble cytokine, soluble IL-2 receptor (sIL-2R) modulates lymphocyte activity. Here, we discovered that soluble IL-2 receptors (sIL-2Rα, sIL-2Rβ) dose-dependently increase cAMP levels in differentiated PC12 cells. sIL-2Rγ and sIL-6Rα have produced no effect. Co-treatment of sIL-2Rs with IL-2 alters cAMP levels in a concentration-dependent manner. This is the first evidence that soluble receptors modulate catecholaminergic cell activity. Thus, soluble cytokine receptors, including the α and β subunits, may represent new therapeutic targets for relevant psychiatric and neurological disorders.  

Soluble cytokine receptors interleukin-2 interleukin-6 PC12 cells cAMP Catecholaminergic activity

References (16)

  1. 1 Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. [DOI]
  2. 2 A review of the cytokine network in multiple myeloma [DOI]
  3. 3 A psychoneuroimmunological perspective to Emil Kraepelins dichotomy [DOI]
  4. 4 Soluble Interleukin-6 Receptor Induces Motor Stereotypies and Co-Localizes with Gp130 in Regions Linked to Cortico-Striato-Thalamo-Cortical Circuits [DOI]
  5. 5 Activation of gp 130 by IL‐6/soluble IL‐6 receptor induces neuronal differentiation [DOI]
  6. 6 Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia [DOI]
  7. 7 Hepatocellular Carcinoma Immunopathogenesis: Clinical Evidence for Global T Cell Defects and an Immunomodulatory Role for Soluble CD25 (sCD25) [DOI]
  8. 8 Impaired desensitization of a human polymorphic α2B-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells [DOI]
  9. 9 Soluble Cytokine Receptors (sIL-2Rα, sIL-2Rβ) Induce Subunit-Specific Behavioral Responses and Accumulate in the Cerebral Cortex and Basal Forebrain [DOI]
  10. 10 Nerve Growth Factor Potentiates p53 DNA Binding but Inhibits Nitric Oxide-Induced Apoptosis in Neuronal PC12 Cells [DOI]
  11. 11 Soluble Cytokine Receptors: Basic Immunology and Clinical Applications [DOI]
  12. 12 Interleukin‐2 Receptor β‐Chain (p70–75) Expressed on Leukemic Cells from Adult T Cell Leukemia Patients [DOI]
  13. 13 Biochemical and functional analysis of soluble human interleukin-2 receptor produced in rodent cells. Solid-phase reconstitution of a receptor-ligand binding reaction. [DOI]
  14. 14 Anti‐Thy‐1‐mediated T cell activation. Role of soluble factors and expression of interleukin 2 receptors on T cells [DOI]
  15. 15 High levels of soluble interleukin 2 receptors released from human retrovirus-infected cells.
  16. 16 Cytokine Receptors: Qualitative and Quantitative Analysis [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

33

Page views

0

PDF downloads

2

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.